China Salt Chemical(SH:600328) Zheng Quan Zhi Xing·2025-08-05 16:20Core Viewpoint - The report outlines the self-examination of insider trading activities related to the major asset restructuring of Zhongyan Inner Mongolia Chemical Co., Ltd. (hereinafter referred to as "Zhongyan Chemical") and its subsidiary Zhongyan (Inner Mongolia) Alkali Industry Co., Ltd. (hereinafter referred to as "Zhongyan Alkali"). The restructuring involves a targeted capital reduction by Zhongyan Alkali, which will subsequently become a wholly-owned subsidiary of Zhongyan Chemical [1][2]. Group 1 - The self-examination period for insider trading activities is defined as the six months prior to the first disclosure of the restructuring transaction (from December 20, 2024, to July 23, 2025) [3][4]. - The scope of the insider trading examination includes directors, senior management, controlling shareholders, and other related parties of both the listed company and the target company [3][4]. - The report indicates that the insider trading activities during the self-examination period do not constitute a violation of the Securities Law of the People's Republic of China, as the involved parties have provided accurate and complete self-reports [11][12]. Group 2 - Specific trading activities by insiders during the self-examination period are detailed, including purchases and sales of shares by various individuals, such as the chairman and vice president of Zhongyan Chemical [5][6]. - The chairman, Zhou Jie, reported buying 20,000 shares on January 2, 2025, and 3,900 shares on January 7, 2025, while other executives also engaged in similar trading activities [5][6]. - The report emphasizes that all involved parties have committed to not using insider information for trading and have provided assurances regarding the legality of their trading actions [6][10].